GreenMark Biomedical
East Lansing, US · Founded 2016 · Delaware corporation · 3 known investors
Biotechin /greenmark-biomedical-inc
Founders & leadership
SB
Steven Bloembergen, PhDExecutive Officer, Director
SB
Steven BloembergenExecutive Officer, Director
KP
Kenneth PientaDirector
FV
Frank van LuttikhuizenDirector
MS
Michael SnyderDirector
JL
Joerg Lahann, Ph.D.Director
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$5MofferedApr 2026 · BiotechnologyRule 506(b)
▶$5MofferedApr 2026 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven Bloembergen PhDExecutive Officer, Director
- Michael SnyderDirector
- Joerg Lahann, PhDDirector
- Offering amount
- $5M
- Minimum investment
- $25K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KofferedJan 2025 · BiotechnologyRule 506(b)
▶$500KofferedJan 2025 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael SnyderDirector
- Steven Bloembergen, PhDExecutive Officer, Director
- Joerg Lahann, Ph.D.Director
- Offering amount
- $500K
- Minimum investment
- $10K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedOct 2022 · 3 investors · BiotechnologyRule 506(b)
▶$500KraisedOct 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joerg Lahann, Ph.D.Director
- Jeff WesleyDirector
- Frank van LuttikhuizenDirector
- Steven BloembergenExecutive Officer, Director
- Michael SnyderDirector
- Offering amount
- $1M
- Amount sold
- $500K
- Minimum investment
- $30K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MofferedJul 2020 · BiotechnologyRule 506(b)
▶$2MofferedJul 2020 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael SnyderDirector
- Joerg LaHann, Ph.D.Director
- Steven BloembergenExecutive Officer, Director
- Kenneth PientaDirector
- Frank van LuttikhuizenDirector
- Offering amount
- $2M
- Minimum investment
- $25K
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.2MraisedMar 2019 · BiotechnologyRule 506(b)
▶$1.2MraisedMar 2019 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank van Luttikhuizen, CPADirector
- Joerg LaHann, Ph.D.Director
- Michael D. SnyderDirector
- Kenneth Pienta, M.D.Director
- Steven Bloembergen, Ph.D.Executive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Minimum investment
- $25K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.